On this page
APECED / APS type 1
APECED / APS type 1 is a rare genetic disorder where the immune system attacks various organs and tissues, particularly endocrine glands, leading to hormonal imbalances. It often presents in childhood and affects multiple body systems.
Available at Jeen Health
Clinical tests that include this
Overview
APECED, also known as Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy, or Autoimmune Polyglandular Syndrome Type 1 (APS Type 1), is a rare inherited condition. It involves the immune system incorrectly identifying the body's own cells as foreign and launching an attack against them, a process called autoimmunity. This leads to a range of symptoms, most commonly affecting hormone-producing glands (endocrine glands), but also often involving the skin, nails, and mucous membranes.
The condition typically begins in childhood, and its severity and specific manifestations can vary greatly between individuals, even within the same family. It is considered a multi-system disorder due to the wide array of potential organs and tissues that can be affected.
Symptoms & clinical features
The clinical features of APECED often develop over time, frequently beginning in early childhood. The three main components historically used to define the condition are chronic mucocutaneous candidiasis (persistent fungal infections of the skin, nails, and mucous membranes), hypoparathyroidism (underactive parathyroid glands), and adrenal insufficiency (underactive adrenal glands, also known as Addison's disease) [PMID:33671216].
Many other autoimmune conditions are associated with APECED. These can include type 1 diabetes, autoimmune hepatitis, autoimmune thyroid disease (such as Hashimoto's thyroiditis or Graves' disease), pernicious anaemia, and vitiligo. Dental enamel defects and absent tooth development (agenesis) can also be present [PMID:28751515]. Hair loss (alopecia) and malabsorption problems affecting the digestive system may also occur.
Video: Genetics 101
Affected organs
APECED primarily affects endocrine glands, which produce hormones vital for various bodily functions. The parathyroid glands, adrenal glands, and often the pancreas (leading to type 1 diabetes) and thyroid gland are commonly targeted. The immune system's attack can cause these glands to become underactive or, less commonly, overactive.
Beyond endocrine organs, the immune system can also affect the skin, leading to chronic fungal infections (candidiasis) and vitiligo. Nails may become brittle or misshapen. The liver can be affected by autoimmune hepatitis, and the gut lining may be targeted, leading to digestive issues. Dental health can also be compromised, with problems like enamel hypoplasia (poor enamel formation) and missing teeth.
Risks & severity
APECED is a condition with significant variability in its presentation and severity. While some individuals may experience only mild symptoms, others can develop severe, life-threatening complications. The age of onset for specific symptoms can range from infancy to adulthood, though initial signs often appear in childhood. For instance, chronic mucocutaneous candidiasis commonly appears first, often in infancy or early childhood, followed by hypoparathyroidism and then adrenal insufficiency [PMID:33671216].
The lifetime risk for various autoimmune conditions associated with APECED is high. For example, nearly all individuals with APECED will develop chronic mucocutaneous candidiasis, with hypoparathyroidism affecting about 80% and adrenal insufficiency about 70-80% [PMID:28751515]. The specific combination and progression of symptoms are unpredictable, making long-term monitoring essential for managing the condition and preventing severe complications.
Genetic causes
APECED is caused by changes (variants) in the *AIRE* gene. This gene provides instructions for making a protein called the autoimmune regulator (AIRE). The AIRE protein plays a critical role in the immune system by helping to 'educate' developing immune cells (specifically T cells) in an organ called the thymus. This education process teaches T cells to recognise the body's own proteins as 'self' and not to attack them.
When variants in the *AIRE* gene lead to a faulty AIRE protein, this education process is impaired. As a result, some T cells that are reactive to the body's own tissues may not be eliminated. These improperly educated T cells can then leave the thymus and mistakenly attack healthy cells and tissues, particularly endocrine glands, leading to the autoimmune features characteristic of APECED. The specific type of variant in the *AIRE* gene can influence the clinical presentation, though more research is needed to fully understand these correlations.
- AIRE autoimmune regulatorThe AIRE gene provides instructions for producing the autoimmune regulator protein, which is critical for immune system development and preventing autoimmune reactions.
Inheritance pattern
APECED is inherited in an autosomal recessive pattern. This means that an individual must inherit two altered copies of the *AIRE* gene - one from each parent - to develop the condition. People who have only one altered copy of the *AIRE* gene are called carriers. Carriers typically do not show symptoms of APECED themselves because their one functional copy of the gene is usually sufficient to produce enough AIRE protein.
When two carriers have a child, there is a 25% chance with each pregnancy that the child will inherit an altered gene from each parent and develop APECED. There is also a 50% chance that the child will be a carrier like their parents, and a 25% chance that the child will inherit two functional copies of the gene and will not be a carrier or have the condition.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
Diagnosis & testing
A diagnosis of APECED is typically suspected based on the presence of characteristic clinical features, especially the triad of chronic mucocutaneous candidiasis, hypoparathyroidism, and adrenal insufficiency. However, because symptoms can appear at different ages and vary in involvement, a definitive diagnosis relies on genetic testing.
Genetic testing for variants in the *AIRE* gene confirms the diagnosis. In the UK, individuals suspected of having APECED may be referred to a clinical genetics service by their GP or specialist. Genetic testing is typically performed through the NHS Genomic Medicine Service (GMS), often following an R-code appropriate for primary immunodeficiencies or endocrine disorders. Genetic counsellors can provide support and information during this process.
Management & lifestyle
The management of APECED is complex and focuses on treating the specific autoimmune conditions and hormonal deficiencies as they arise. There is no cure for the underlying genetic cause, so treatment aims to manage symptoms, prevent complications, and improve quality of life. This typically involves a multidisciplinary team of specialists, including endocrinologists, immunologists, dermatologists, and gastroenterologists.
For example, hypoparathyroidism is generally managed with calcium and vitamin D supplementation. Adrenal insufficiency requires lifelong hormone replacement therapy (e.g., hydrocortisone and fludrocortisone). Chronic candidiasis is treated with antifungal medications, often on an ongoing basis. Regular monitoring for the development of new autoimmune conditions is crucial, as symptoms can evolve over time. This includes routine blood tests to check hormone levels and immune markers. Individuals with APECED should generally carry emergency steroid information if they have adrenal insufficiency and be aware of 'sick day rules' for managing intercurrent illnesses to prevent adrenal crises. Genetic counsellors can aid in understanding long-term care plans and implications for family members.
UK care pathway
In the UK, suspected cases of APECED are usually referred to specialist services, typically through a GP or paediatrician. Genetic testing to confirm the diagnosis is provided by the NHS Genomic Medicine Service (GMS), often initiated by a clinical genetics team. Genetic counsellors play a vital role in providing information about the condition, its inheritance, and implications for family planning. The management plan is then developed by various specialist clinicians as part of a coordinated NHS care pathway.
Frequently asked questions
Is APECED a curable condition?
APECED is a genetic condition, and currently, there is no cure for the underlying genetic cause. However, many of the symptoms and associated autoimmune conditions can be effectively managed with lifelong treatments and monitoring. This includes hormone replacement therapy and antifungal medications.
How common is APECED?
APECED is considered a rare condition. Its exact prevalence is not well established globally, but it is known to be more common in certain specific populations, such as Finnish, Iranian Jewish, and Sardinian communities.
Can APECED affect my children?
APECED is inherited in an autosomal recessive pattern. If you have APECED, all your children will inherit one altered copy of the *AIRE* gene from you. Whether they develop the condition depends on the genetic status of your partner. If your partner is also a carrier, there would be a 50% chance for each child to be a carrier and a 25% chance to have APECED.
What kind of doctors will I need to see for APECED?
Managing APECED typically requires a team of specialists. This often includes an endocrinologist for hormone-related issues, an immunologist for immune system oversight, a dermatologist for skin and nail problems, and potentially a gastroenterologist, dentist, or other specialists depending on which organs are affected. A genetic counsellor can help coordinate care and provide ongoing support.
Are there any specific lifestyle changes recommended for APECED?
While no specific lifestyle changes can cure APECED, maintaining a healthy lifestyle, including a balanced diet and regular exercise, can support overall well-being. Adhering strictly to prescribed medications and attending all recommended monitoring appointments are crucial. For individuals with adrenal insufficiency, being aware of 'sick day rules' and emergency steroid protocols is vital.